Alpha Omega Wealth Management’s Biogen BIIB Stock Holding History

Alpha Omega Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-430	Closed	-$101K	–	244
2019 Q2	$101K	Hold	430	–	–	0.04%	198
2019 Q1	$102K	Buy	430 +20	+5%	+$6.3K	0.05%	190
2018 Q4	$123K	Sell	410 -15	-4%	-$4.79K	0.06%	157
2018 Q3	$150K	Hold	425	–	–	0.07%	148
2018 Q2	$123K	Hold	425	–	–	0.06%	157
2018 Q1	$116K	Hold	425	–	–	0.06%	155
2017 Q4	$135K	Hold	425	–	–	0.07%	150
2017 Q3	$133K	Buy	425 +100	+31%	+$29.6K	0.07%	153
2017 Q2	$88K	Hold	325	–	–	0.05%	181
2017 Q1	$89K	Buy	325 +20	+7%	+$5.66K	0.05%	178
2016 Q4	$86K	Buy	+305	New	+$90.4K	0.05%	183

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alpha Omega Wealth Management's BIIB Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of Biogen (BIIB) in Q3 2019, closing a stake of 430 shares — an estimated $101K sold.

Alpha Omega Wealth Management first reported a position in BIIB in Q4 2016 and held it in 11 quarters. The position peaked at $150K in Q3 2018. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Alpha Omega Wealth Management reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
Alpha Omega Wealth Management sold 430 Biogen shares in Q3 2019, an estimated $101K.
Alpha Omega Wealth Management first reported a position in Biogen in Q4 2016 and held it in 11 quarters.
Alpha Omega Wealth Management's Biogen position peaked at $150K in Q3 2018.
988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.